TCRT-PGEN Fundamental & Technical Discussion Board - Short interest in the XBI @ 107% - TCRT-PGEN Fundamental & Technical Discussion Board - InvestorVillage


TCRT-PGEN Fundamental & Technical Discussion Board
This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group

Group: TCRT-PGEN Fundamental & Technical Discussion Board   /  Message Board  /  Read Message

 
 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  27729 of 28328  at  5/19/2022 7:22:44 PM  by

clsm


 In response to msg 27727 by  dachmeister4u
view thread

Re: Short interest in the XBI @ 107%

''Take solace that the only all-metastatic-cancers trial that is open (? & recruiting?) at the NCI is also using Sleeping Beauty in TCR-T.''

Wrong.

''(Don't be fooled by blogs that say other firms are engaged with the NCI in viral cancers or germline cancers are also metastatic cancers --- those are not metastatic and are rare in incidence).''

Wrong again. GILD had a number of CRADAs with the NCI, two of which were for TCR-T cell therapies targeting HPV16*. Data from both were published and patients had metastatic disease [1,2].

Refs:
1 (see Fig. 1c, d and e) https://www.nature.com/articles/s41591-020-01225-1
2 (see Fig. 1c and d) https://ascopubs.org/doi/10.1200/JCO.18.02424

* This is the strain most likely to cause cancer and is present in close to half of all cervical, in many vaginal and vulvar, penile, anal, those of head and neck, and some other types.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 2  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board


Financial Market Data provided by
.
Loading...